Managing Partner, Hong Kong
Dr. Mirko Scherer joined the TVM Capital Life Science office in Hong Kong as Managing Partner and leads the investment activities of China BioPharma Fund I.
Mirko is an experienced biotechnology executive and has led numerous financing and M&A transactions, in both public and private markets, in Europe and the U.S. over 15 years. He consulted as Managing Director for MPM Capital focusing on deal sourcing for MPM in Europe. Mirko was also a co-founder and partner at KI Kapital which specializes in consulting and lead investments in the life science industries. Prior to working in the venture capital industry, Mirko co-founded GPC Biotech (Munich and Princeton, NJ) and served as Chief Financial Officer for a decade. GPC Biotech engaged in numerous pharmaceutical alliances with companies such as Sanofi Aventis, Boehringer Ingelheim, Altana (now part of Takeda), Yakult, and Pharmion (now part of Celgene).
Over the last 15 years Mirko has established an extensive network in the U.S. and European biotechnology and venture capital industry. Prior to his time at GPC Biotech Mirko worked as a consultant at the Boston Consulting Group. He has served on the Board of the Frankfurt Stock Exchange and is currently a board member of the Stichting Preferente Aandelen QIAGEN.
Mirko holds an MBA from Harvard Business School, Boston. He also earned a Doctorate in Finance from the European Business School in Oestrich-Winkel/Germany and a degree in business administration from the University of Mannheim/Germany.